8225 Share Price

Open 0.20 Change Price %
High 0.20 1 Day -0.01 -4.76
Low 0.20 1 Week -0.02 -9.09
Close 0.20 1 Month -0.01 -4.76
Volume 360000 1 Year -0.06 -23.08
52 Week High 0.29
52 Week Low 0.15
8225 Important Levels
Resistance 2 0.20
Resistance 1 0.20
Pivot 0.20
Support 1 0.20
Support 2 0.20
HKG HongKong Most Active Stocks
1051 0.14 0.00%
0566 3.91 0.00%
1188 0.23 15.00%
3988 3.60 1.12%
1398 4.85 0.41%
0261 0.01 0.00%
0939 5.89 0.86%
0981 1.03 0.00%
2324 0.05 -16.67%
0651 0.23 0.00%
More..
HKG HongKong Top Gainers Stocks
0274 0.04 33.33%
0915 5.42 26.64%
8086 0.14 16.67%
2309 0.52 15.56%
1188 0.23 15.00%
0343 0.94 14.63%
3344 1.28 14.29%
8286 0.57 14.00%
8249 0.57 14.00%
8271 0.26 13.04%
More..
HKG HongKong Top Losers Stocks
4333 60.00 -25.00%
2324 0.05 -16.67%
8002 4.00 -15.97%
1176 0.99 -13.91%
8155 0.07 -12.50%
0619 0.07 -12.50%
8153 1.22 -11.59%
0231 0.08 -11.11%
0877 3.36 -11.11%
0381 0.09 -10.00%
More..

Venturepharm Laboratories Ltd. (HKG: 8225)

8225 Technical Analysis 3
As on 8th Dec 2016 8225 Share Price closed @ 0.20 and we RECOMMEND Sell for LONG-TERM with Stoploss of 0.23 & Sell for SHORT-TERM with Stoploss of 0.21 we also expect STOCK to react on Following IMPORTANT LEVELS.
8225 Target for December
1st Target up-side 0.25
2nd Target up-side 0.28
3rd Target up-side 0.3
1st Target down-side 0.19
2nd Target down-side 0.16
3rd Target down-side 0.14
8225 Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Drug Manufacturers - Major
Offical website
8225 Address
8225
Interactive Technical Analysis Chart Venturepharm Laboratories Ltd. ( 8225 HKG HongKong )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Venturepharm Laboratories Ltd.
8225 Business Profile
Venturepharm Laboratories Limited, an investment holding company, provides drug development outsourcing, new drug research, drug delivery, clinical research, product registration, and marketing and sales services for biotechnology and pharmaceutical companies. The company engages in the research, development, and production of new drug preparation, raw materials, supplementary materials, biodrugs, natural drugs, and synthetic drugs; manufacture and sale of active pharmaceutical ingredients products; technological transfer of and services for the research and development of biodrugs, natural drugs, and synthetic drugs; and pharmacodynamic and clinical research of drugs. It also offers clinical research services, including phase I clinical and bioequivalence studies, phase II-III clinical studies, phase IV post-marketing clinical studies, data management and medical statistics, and medical administration related services; pre-clinical research services; Venturepharm-discovery services; and pharmaceutical development, contract research, and regulatory affairs services. The company provides its products and services in various therapeutic areas, such as endocrine, CNS, cardiovascular disease, dermatosis, cancer, AIDS, allergy, and antibiotics. Venturepharm Laboratories Limited offers its products under Venturepharm brand in the People's Republic of China and VPS-CRO brand internationally. The company was founded in 1998 and is based in Beijing, the People's Republic of China.